Trial intelligence / Profile preview

Paroxetine versus cognitive behavioural therapy for late-life panic disorder

NL-OMON23124Active, not recruiting

Sponsor
Radboud University
Start
Jan 1999
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of paroxetine in panic disorder and agoraphobia (3 arms), sponsored by Radboud University. Primary endpoints: Agoraphobic Cognitions Questionnaire score and Mobility Inventory avoidance scale score. Started Jan 1999; status: active, not recruiting.

02

Drugs

paroxetine
03

Conditions

panic disorderagoraphobia

Beyond the preview

Go deeper on NL-OMON23124.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON23124.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call